These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17054419)

  • 21. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
    Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNAs, polyphenols, and chronic disease.
    Bladé C; Baselga-Escudero L; Salvadó MJ; Arola-Arnal A
    Mol Nutr Food Res; 2013 Jan; 57(1):58-70. PubMed ID: 23165995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modern concepts of gene polymorphisms, which regulate lipid metabolism].
    Kirillova OO
    Vopr Pitan; 2012; 81(4):48-52. PubMed ID: 23156051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into cardiovascular and lipid metabolomics.
    Giovane A; Balestrieri A; Napoli C
    J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes.
    Junien C; Nathanielsz P
    Obes Rev; 2007 Nov; 8(6):487-502. PubMed ID: 17949354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular disease in genotypes for obesity and diabetes.
    McCune SA
    Nutrition; 1989; 5(1):52-5. PubMed ID: 2520259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism, lifestyle and bipolar affective disorder.
    Morriss R; Mohammed FA
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):94-101. PubMed ID: 16280342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty liver disease in obese children--relation to other metabolic risk factors.
    Volovelsky O; Weiss R
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():59-64. PubMed ID: 21905818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body composition phenotypes in pathways to obesity and the metabolic syndrome.
    Dulloo AG; Jacquet J; Solinas G; Montani JP; Schutz Y
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S4-17. PubMed ID: 21151146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding?
    Griffin JL; Vidal-Puig A
    Physiol Genomics; 2008 Jun; 34(1):1-5. PubMed ID: 18413782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nutrigenomics. Scientific basis, status and perspectives of application].
    Joost HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1011-9. PubMed ID: 17013774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies.
    Jin Q; Ma RCW
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?
    Griffin JL
    Philos Trans R Soc Lond B Biol Sci; 2006 Jan; 361(1465):147-61. PubMed ID: 16553314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes.
    Park S; Sadanala KC; Kim EK
    Mol Cells; 2015 Jul; 38(7):587-96. PubMed ID: 26072981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
    Wang N; Zhu F; Chen L; Chen K
    Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.